HOME >> BIOLOGY >> NEWS
Other highlights from the July 10 JNCI

Nanobubbles Deliver Targeted Cancer Drugs Using Ultrasound

A new targeted drug delivery method uses ultrasound to image tumors, while also releasing the drug from nanobubbles into the tumor.

Cancer drugs can be targeted to tumors by delivering them in packets of nanoparticles, then releasing them with ultrasound. But this approach can be difficult because it requires a way to image the tumor prior to treatment.

Natalya Rapoport, Ph.D., D.Sc., of the University of Utah in Salt Lake City and colleagues describe a new method of drug delivery that may address this problem. Nanobubbles filled with the chemotherapy drug doxorubicin were injected into mice. The bubbles accumulated in the tumors, where they combined to form larger microbubbles. When exposed to ultrasound, the bubbles generated echoes, which made it possible to image the tumor. The sound energy from the ultrasound popped the bubbles, releasing the drug. In mice treated with this method, the nanobubbles were more effective at blocking tumor growth than other nanoparticle delivery methods.

Microbubble formulations have been developed for combining ultrasonic tumor imaging and ultrasound-enhanced chemotherapeutic treatment, the authors write.

Contact: Natalya Rapoport, natasha.rapoport@m.cc.utah.edu, (801) 581-8990


Gene May Promote Resistance to Chemotherapy Drugs

A gene known as HDAC1 may be a good target for drugs to treat multidrug-resistant neuroblastoma, a cancer that develops in immature nerve cells and is prevalent in children.

Drug resistance could explain why about 50% of high-risk neuroblastoma patients die of the disease. Nino Keshelava, M.D., of Childrens Hospital Los Angeles and colleagues studied several human neuroblastoma cell lines to identify genes that cause drug resistance.

They found that HDAC1 was overexpressed in m
'"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
10-Jul-2007


Page: 1 2

Related biology news :

1. Other highlights in the Aug. 7 JNCI
2. Other highlights in the July 24 JNCI
3. Other highlights in JNCI, June 26
4. Other highlights in JNCI, June 12
5. Other highlights from the June 6 JNCI
6. Other highlights in the May 16 JNCI
7. Other highlights from the April 18 Journal of the National Cancer Institute
8. Other highlights from the March 21 JNCI
9. Other highlights in the March 7 JNCI
10. Other highlights in the Feb. 21 JNCI
11. Other highlights in the Jan. 17 JNCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/19/2020)... Conn. (PRWEB) , ... March 17, 2020 , ... ... develops tools for characterizing microbiome populations down to the strain level, recently unveiled ... The Shoreline Wave amplicon kit contains the same innovative amplification capabilities as the ...
(Date:3/13/2020)... (PRWEB) , ... March 13, 2020 , ... ... agreement with Vivorte Inc. to be the exclusive distributor of the Louisville-based company’s ... marketing, and medical education expertise to distribute Vivorte’s calcium phosphate-based bone allograft (Trabexus) ...
(Date:3/9/2020)... ... March 09, 2020 , ... Application transformation ... as enterprises sought to achieve competitive advantage by transforming their core applications, ... transformation efforts delivered the intended consequences. , Application transformation refers to the ...
Breaking Biology News(10 mins):
(Date:4/1/2020)... Calif. (PRWEB) , ... March 31, 2020 , ... Carterra® ... Institute for Immunology (LJI), announced today that they will use Carterra’s proprietary LSA™ platform ... therapeutic candidates to the clinic as early as this summer. , La Jolla ...
(Date:3/27/2020)... ... 2020 , ... iFirst Medical Technologies, Inc., a leader in handheld diagnostic devices, ... "COVID-19 poses a grave danger to public health here in the U.S. and around ... act. Broad-based testing and on-the-spot results promise to slow the spread and save human ...
(Date:3/13/2020)... ... March 12, 2020 , ... ... APC Microbiome Ireland SFI Research Center (APC), a pioneer in the field of ... and play a significant role in human health, based at University College Cork ...
(Date:3/10/2020)... , ... March 10, 2020 ... ... full-service cold chain biopharmaceutical engineering firm, is pleased to announce the addition ... on combination medical device qualification and validation in the biopharmaceutical cold chain. ...
Breaking Biology Technology:
Cached News: